This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Jan 27;391(10118):287-289.

doi: 10.1016/S0140-6736(17)32865-9. Epub 2017 Nov 13.

Treatment concentration of high-sensitivity C-reactive protein

Erin D Michos¹, Roger S Blumenthal²

Affiliations

Affiliations

¹ Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA. Electronic address: edonnell@jhmi.edu.
² Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA.

PMID: 29146121
DOI: 10.1016/S0140-6736(17)32865-9

Comment

Treatment concentration of high-sensitivity C-reactive protein

Erin D Michos et al. Lancet. 2018.

. 2018 Jan 27;391(10118):287-289.

doi: 10.1016/S0140-6736(17)32865-9. Epub 2017 Nov 13.

Authors

Erin D Michos¹, Roger S Blumenthal²

Affiliations

¹ Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA. Electronic address: edonnell@jhmi.edu.
² Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA.

PMID: 29146121
DOI: 10.1016/S0140-6736(17)32865-9

No abstract available

PubMed Disclaimer

Comment on

Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial.
Ridker PM, MacFadyen JG, Everett BM, Libby P, Thuren T, Glynn RJ; CANTOS Trial Group. Ridker PM, et al. Lancet. 2018 Jan 27;391(10118):319-328. doi: 10.1016/S0140-6736(17)32814-3. Epub 2017 Nov 13. Lancet. 2018. PMID: 29146124

Publication types

Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program